As compared to FDG PET imaging, where region growing of 30–40% of the tumor’s SUV-max values has been shown previously to approximate the true tumor volume as assessed using histology, to the best of our knowledge, studies defining the threshold for accurate prostate tumor volume delineation have not been reported using PSMA-targeting ligands [39]. This evidence concerns the gene FOLH1 and prostate neoplasm.